Figure 2 Cumulative number of new Gd+ lesions and T2-hyperintense lesions at week 24 in the placebo + GA group and the natalizumab + GA group
Gd+ = gadolinium-enhancing; GA = glatiramer acetate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.